相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Halogen-Dance-Based Synthesis of Phosphonomethoxyethyl (PME) Substituted 2-Aminothiazoles as Potent Inhibitors of Bacterial Adenylate Cyclases
Michal Cesnek et al.
CHEMMEDCHEM (2022)
DISCOVERY OF IBD3540: A NOVEL GUT-RESTRICTED GLUTAMATE CARBOXYPEPTIDASE II INHIBITOR WITH ORAL ACTIVITY IN MOUSE COLITIS MODELS
Diane Peters et al.
INFLAMMATORY BOWEL DISEASES (2022)
Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis
Carolyn Tallon et al.
NEUROTHERAPEUTICS (2022)
C1′-Branched acyclic nucleoside phosphonates mimicking adenosine monophosphate: Potent inhibitors of Trypanosoma brucei adenine phosphoribosyltransferase
Filip Kalcic et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases
Petra Brehova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of Modified Amidate (ProTide) Prodrugs of Tenofovir with Enhanced Antiviral Properties
Filip Kalcic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
1,2,4-Thiadiazole acyclic nucleoside phosphonates as inhibitors of cysteine dependent enzymes cathepsin K and GSK-3β
Alice Pomeislova et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Prostate-Specific Membrane Antigen (PSMA) Promotes Angiogenesis of Glioblastoma Through Interacting With ITGB4 and Regulating NF-κB Signaling Pathway
Yang Gao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Acyclic nucleoside phosphonates with adenine nucleobase inhibit Trypanosoma brucei adenine phosphoribosyltransferase in vitro
Eva Dolezelova et al.
SCIENTIFIC REPORTS (2021)
PSMA Theranostics: Current Landscape and Future Outlook
Hanbo Zhang et al.
CANCERS (2021)
Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection
Kazumoto Murata et al.
HEPATOLOGY (2020)
N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications
Joseph H. Neale et al.
PROGRESS IN NEUROBIOLOGY (2020)
Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection
Hong Zhang et al.
ANTIVIRAL RESEARCH (2020)
Acyclic nucleoside phosphonates as possible chemotherapeutics against Trypanosoma brucei
David Teran
DRUG DISCOVERY TODAY (2020)
Hypoxanthine-Guanine Phosphoribosyltransferase Is Dispensable for Mycobacterium smegmatis Viability
Zdenek Knejzlik et al.
JOURNAL OF BACTERIOLOGY (2020)
Successful Use of Cidofovir in an Immunocompetent Child With Severe Adenoviral Sepsis
Alicia M. Alcamo et al.
PEDIATRICS (2020)
Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial
Hyung Joon Yim et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review
Raquel Scherer de Fraga et al.
JOURNAL OF GASTROENTEROLOGY (2020)
PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
Wallace Jones et al.
CANCERS (2020)
Identification of 2-PMPA as a novel inhibitor of cytosolic carboxypeptidases
Ruixue Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
Yeon Woo Jung et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
An improved synthesis of adefovir and related analogues
David J. Jones et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2019)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Francisco M. Marty et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Current state-of-the-art pharmacotherapy for the management of hepatitis B infection
Hans L. Tillmann et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Fifty Years in Search of Selective Antiviral Drugs
Erik De Clercq
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer
Tu Nguyen et al.
CELL REPORTS (2019)
Phosphonate prodrugs: an overview and recent advances
Kenneth M. Heidel et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Enhanced Oral Bioavailability of 2-(Phosphonomethyl)-pentanedioic Acid (2-PMPA) from its (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (ODOL)-Based Prodrugs
Ranjeet P. Dash et al.
MOLECULAR PHARMACEUTICS (2019)
The prodrug approach in the era of drug design
Anas Najjar et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Sulfide, sulfoxide and sulfone bridged acyclic nucleoside phosphonates as inhibitors of the Plasmodium falciparum and human 6-oxopurine phosphoribosyltransferases: Synthesis and evaluation
Tomas Klejch et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Spontaneous Loss-of-Function Dock2 Mutation Alters Murine Colitis Sensitivity and Is a Confounding Variable in Inflammatory Bowel Disease Research
Diane E. Peters et al.
CROHNS & COLITIS 360 (2019)
Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Charalambos Kaittanis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold
Katherine L. Seley-Radtke et al.
ANTIVIRAL RESEARCH (2018)
Tanovea (R) for the treatment of lymphoma in dogs
Erik De Clercq
BIOCHEMICAL PHARMACOLOGY (2018)
Nucleobase Modified Adefovir (PMEA) Analogues as Potent and Selective Inhibitors of Adenylate Cyclases from Bordetella pertussis and Bacillus anthracis
Michal Cesnek et al.
CHEMMEDCHEM (2018)
Model of population pharmacokinetics of cidofovir in immunocompromised children with cytomegalovirus and adenovirus infection
Nadege Neant et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Amidate Prodrugs of Cyclic 9-(S)-[3-Hydroxy-2(phosphonomethoxy)propyl]adenine with Potent Anti-Herpesvirus Activity
Min Luo et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Evaluation of the Trypanosoma brucei 6-oxopurine salvage pathway as a potential target for drug discovery
Eva Dolezelova et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Adefovir-induced Fanconi syndrome associated with osteomalacia
Samel Park et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2018)
Design of Plasmodium vivax Hypoxanthine-Guanine Phosphoribosyltransferase Inhibitors as Potential Antimalarial Therapeutics
Dianne T. Keough et al.
ACS CHEMICAL BIOLOGY (2018)
Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease
Abhijit A. Date et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs
Min Luo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals
Marcela Krecmerova
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA
Takahiro Nonaka et al.
MOLECULAR PAIN (2017)
Enhanced Brain Delivery of 2-(Phosphonomethyl)pentanedioic Acid Following Intranasal Administration of Its γ-Substituted Ester Prodrugs
Michael Nedelcovych et al.
MOLECULAR PHARMACEUTICS (2017)
NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication
Rafal T. Olszewski et al.
NEUROCHEMICAL RESEARCH (2017)
New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity
Marcela Krecmerova et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors
Gabriel Birkus et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
Erik De Clercq
BIOCHEMICAL PHARMACOLOGY (2016)
Design and Synthesis of Fluorescent Acyclic Nucleoside Phosphonates as Potent Inhibitors of Bacterial Adenylate Cyclases
Petra Brehova et al.
CHEMMEDCHEM (2016)
Discovery of Orally Available Prodrugs of the Glutamate Carboxypeptidase II (GCPII) Inhibitor 2-Phosphonomethylpentanedioic Acid (2-PMPA)
Pavel Majer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brain
Zhi Zhang et al.
NEUROBIOLOGY OF DISEASE (2016)
Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent
Kristell L. S. Chatalic et al.
THERANOSTICS (2016)
Experimental Treatment of Ebola Virus Disease with Brincidofovir
Jake Dunning et al.
PLOS ONE (2016)
FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities
Rana Rais et al.
JCI INSIGHT (2016)
Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia
G. Andrei et al.
ANTIVIRAL RESEARCH (2015)
Bisamidate Prodrugs of 2-Substituted 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis
Michal Cesnek et al.
CHEMMEDCHEM (2015)
PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
Jeanne M. Marrazzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Commercial Synthesis of Azilsartan Kamedoxomil: An Angiotensin II Receptor Blocker
Srinivas Garaga et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2015)
Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients
Dan-Hong Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Antiviral treatment of feline immunodeficiency virus-infected cats with (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine
Elien Taffin et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2015)
Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration
Rana Rais et al.
PLOS ONE (2015)
Amidate Prodrugs of 9-[2-(Phosphonomethoxy)Ethyl]Adenine as Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis
Marketa Smidkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs
Ugo Pradere et al.
CHEMICAL REVIEWS (2014)
9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and its prodrugs: Optimized preparation, including identification of by-products formed, and antiviral evaluation in vitro
Marcela Krecmerova et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxia
Gene G. Gurkoff et al.
BRAIN RESEARCH (2013)
Safety of Tenofovir During Pregnancy for the Mother and Fetus: A Systematic Review
Liming Wang et al.
CLINICAL INFECTIOUS DISEASES (2013)
NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test
Karolina J. Janczura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review
Du Hwan Kim et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2013)
SAFETY ASSESSMENT IN PIGS OF AN EXPERIMENTAL MOLECULE WITH IN-VITRO ANTIVIRAL ACTIVITY AGAINST AFRICAN SWINE FEVER
S. Roels et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2013)
Inhibition of the Escherichia coli 6-Oxopurine Phosphoribosyltransferases by Nucleoside Phosphonates: Potential for New Antibacterial Agents
Dianne T. Keough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group Are Potent Inhibitors of 6-Oxopurine Phosphoribosyltransferases and Have Antimalarial Activity
Dianne T. Keough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Evolution of an Amino Acid Based Prodrug Approach: Stay Tuned
Ivan S. Krylov et al.
MOLECULAR PHARMACEUTICS (2013)
Medicinal Chemistry of Fluorinated Cyclic and Acyclic Nucleoside Phosphonates
Ondrej Baszczynski et al.
MEDICINAL RESEARCH REVIEWS (2013)
The Acyclic Nucleoside Phosphonates (ANPs): Antonin Holy's Legacy
Erik De Clercq
MEDICINAL RESEARCH REVIEWS (2013)
Pharmacokinetics and Pharmacodynamics of the Glutamate Carboxypeptidase II Inhibitor 2-MPPA Show Prolonged Alleviation of Neuropathic Pain through an Indirect Mechanism
James J. Vornov et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants
George K. Siberry et al.
AIDS (2012)
Synthesis of purine N9-[2-hydroxy-3-O-(phosphonomethoxy)propyl] derivatives and their side-chain modified analogs as potential antimalarial agents
Marcela Krecmerova et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Structure-Activity Relationships of Glutamate Carboxypeptidase II (GCPII) Inhibitors
D. V. Ferraris et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
C. Barinka et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (VistideA®)
Robin E. A. Tjon Pian Gi et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2012)
Synthesis of Novel N-Branched Acyclic Nucleoside Phosphonates As Potent and Selective Inhibitors of Human, Plasmodium falciparum and Plasmodium vivax 6-Oxopurine Phosphoribosyltransferases
Dana Hockova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Preexposure Prophylaxis for HIV Infection among African Women
Lut Van Damme et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis
Kristen A. Rahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Pregnancy and Infant Outcomes among HIV-Infected Women Taking Long-Term ART with and without Tenofovir in the DART Trial
Diana M. Gibb et al.
PLOS MEDICINE (2012)
NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia
R. T. Olszewski et al.
TRANSLATIONAL PSYCHIATRY (2012)
The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond
Erik De Clercq
BIOCHEMICAL PHARMACOLOGY (2011)
Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy) propyl] adenine
Jacqueline Ruiz et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: Inhibitors of hepatitis C virus and HIV-1 replication
Nadejda Valiaeva et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir
Larryn W. Peterson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI
Jun-Feng Feng et al.
BRAIN RESEARCH (2011)
6-Oxopurine Phosphoribosyltransferase: A Target for the Development of Antimalarial Drugs
John De Jersey et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
A novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities
Petr Jansa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Tyrosine-Based 1-(S)[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) Prodrugs: Synthesis, Stability, Antiviral Activity, and in Vivo Transport Studies
Valeria M. Zalcharova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Atripla (R)) A Review of its Use in the Management of HIV Infection
Emma D. Deeks et al.
DRUGS (2010)
The Acyclic 2,4-Diaminopyrimidine Nucleoside Phosphonate Acts as a Purine Mimetic in HIV-1 Reverse Transcriptase DNA Polymerization
Brian D. Herman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Synthesis of Ester Prodrugs of 9-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as Anti-Poxvirus Agents
Marcela Krecmerova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism
Zheng-Xiong Xi et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Cidofovir Activity against Poxvirus Infections
Graciela Andrei et al.
VIRUSES-BASEL (2010)
INHIBITION OF HUMAN PURINE NUCLEOSIDE PHOSPHORYLASE BY TENOFOVIR PHOSPHATE CONGENERS
Ivan Votruba et al.
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS (2010)
The Octadecyloxyethyl Ester of (S)-9-[3-Hydroxy-2-(Phosphonomethoxy) Propyl]Adenine Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication in Genotype 1A, 1B, and 2A Replicons
David L. Wyles et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art
Karl Y. Hostetler
ANTIVIRAL RESEARCH (2009)
Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses
Nadejda Valiaeva et al.
ANTIVIRAL RESEARCH (2009)
Antiviral Drug Discovery: Ten More Compounds, and Ten More Stories (Part B)
Erik De Clercq
MEDICINAL RESEARCH REVIEWS (2009)
Efficient Synthesis of Olmesartan Medoxomil, an Antihypertensive Drug
Karrothu Srihari Babu et al.
SYNTHETIC COMMUNICATIONS (2009)
Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine
Lieve Naesens et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Study of chemical stability of antivirally active 5-azacytosine acyclic nucleoside phosphonates using NMR spectroscopy
Martin Dracinsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
GS-9219 - A novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma
Hans Reiser et al.
CLINICAL CANCER RESEARCH (2008)
Human N-6-methyl-AMP/damp aminohydrolase (abacavir 5 '-monophosphate deaminase) is capable of metabolizing N-6-substituted purine acyclic nucleoside phosphonates
Marketa Schinkmanova et al.
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS (2008)
Pradefovir: A prodrug that targets adefovir to the liver for the treatment of hepatitis B
K. Raja Reddy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Serine peptide phosphoester prodrugs of cyclic cidofovir: Synthesis, transport, and antiviral activity
Ulrika Eriksson et al.
MOLECULAR PHARMACEUTICS (2008)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Design, synthesis and anti-HIV activity of homologous PMEA derivatives
Chang Hyun Oh et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2008)
Ester prodrugs of cyclic 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine:: Synthesis and antiviral activity
Marcela Krecmerova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily
Christophe Hezode et al.
JOURNAL OF HEPATOLOGY (2007)
Acyclic nucleoside phosphonates: Past, present and future - Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: The phosphonate bridge
E. De Clercq
BIOCHEMICAL PHARMACOLOGY (2007)
Antiviral activity of triazine analogues of 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine (cidofovir) and related compounds
Marcela Krecmerova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir
Dionissios Neofytos et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
The preventive and therapeutic effects of GCPIl (NAALADase) inhibition on painful and sensory diabetic neuropathy
W. Zhang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Alkoxyakl esters of (S)-9-[3-Hydroxy-2-(phosphonomethoxy)propyl] adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro
Karl Y. Hostetler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
N6-Methyl-AMP aminohydrolase activates N6-substituted purine acyclic nucleoside phosphonates
M Schinkmanová et al.
BIOCHEMICAL PHARMACOLOGY (2006)
cycloSal phosphates as chemical Trojan horses for intracellular nucleotide and glycosylmonophosphate delivery -: Chemistry meets biology
C Meier
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2006)
2-Phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice
JJ Luszczki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules
C. Meier et al.
ANTIVIRAL RESEARCH (2006)
cycloSal-PMEA and cycloAmb-PMEA:: Potentially new phosphonate prodrugs based on the cycloSal-pronucleotide approach
C Meier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Acyclic nucleoside phosphonates: A key class of antiviral drugs
E De Clercq et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency
HL Fontaine et al.
TRANSPLANTATION (2005)
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693
JP van der Post et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Radiolabeled small-molecule ligands for prostate-specific membrane antigen:: In vivo imaging in experimental models of prostate cancer
CA Foss et al.
CLINICAL CANCER RESEARCH (2005)
Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue
WA Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Simple transformation of thymine 1-[3-hydroxy-2-(phosphono-methoxy)propyl] derivatives to their 1-[3-fluoro-2(phosphonomethoxy)propyl] counterparts
K Pomeisl et al.
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS (2005)
Tenofovir disoproxil fumarate - A review of its use in the management of HIV infection
KA Lyseng-Williamson et al.
DRUGS (2005)
Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines
E De Clercq et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2005)
Design, synthesis, and characterization of a series of cytochrome P450 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver
MD Erion et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies
H Izzedine et al.
KIDNEY INTERNATIONAL (2004)
Amino acids at the N- and C-termini of human glutamate carboxypeptidase II are required for enzymatic activity and proper folding
C Barinka et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxylpyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity
D Hocková et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models
GD Ghadge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Synthesis and biological evaluation of hydroxamate-based inhibitors of glutamate carboxypeptidase II
D Stoermer et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Mechanisms in cutaneous drug hypersensitivity reactions
PS Friedmann et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II:: Discovery of an orally active GCP II inhibitor
P Majer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Olmesartan medoxomil: An angiotensin II-receptor blocker
JA Brousil et al.
CLINICAL THERAPEUTICS (2003)
Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis
DL Wolf et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Phosphonomethoxyalkyl analogs of nucleotides
A Holy
CURRENT PHARMACEUTICAL DESIGN (2003)
Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures
J van Gelder et al.
DRUG METABOLISM AND DISPOSITION (2002)
Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro
JR Beadle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates
J Balzarini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
6-[2-(phosphonomethoxy)alkoxy]pyrimidines with antiviral activity
A Holy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir
ER Kern et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors
T Cihlar et al.
ANTIVIRAL RESEARCH (2002)
GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats
W Zhang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
Synthesis and cytostatic activity of N-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, 2,6-diaminopurines and related compounds
A Holy et al.
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS (2001)
Design of NAALADase inhibitors: A novel neuroprotective strategy
PF Jackson et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340
H Chapman et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2001)
NAALADase inhibition reduces alcohol consumption in the alcohol-preferring (P) line of rats
DL McKinzie et al.
ADDICTION BIOLOGY (2000)
Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase
A Esteban-Gamboa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
